agilon health (NYSE:AGL) Shares Up 5.6% Following Analyst Upgrade

agilon health, inc. (NYSE:AGL) rose 5.6% during trading on Thursday after Royal Bank of Canada raised their price target on the stock from $3.00 to $3.50. Royal Bank of Canada currently has an outperform rating on the stock. agilon health traded as high as $3.58 and last traded at $3.55. Approximately 318,263 shares were traded during trading, a decline of 94% from the average daily volume of 5,431,873 shares. The stock had previously closed at $3.36.

Several other equities research analysts have also recently issued reports on the stock. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and raised their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Macquarie initiated coverage on shares of agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price on the stock. Sanford C. Bernstein raised their target price on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research report on Wednesday, January 15th. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Finally, William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $3.95.

Insider Buying and Selling at agilon health

In other news, Director John William Wulf acquired 45,000 shares of the company’s stock in a transaction dated Thursday, December 5th. The shares were bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the purchase, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Karen Mcloughlin acquired 25,000 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were purchased at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the purchase, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 77,500 shares of company stock valued at $169,600 over the last ninety days. Corporate insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. raised its stake in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the period. Inspire Investing LLC grew its holdings in agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after acquiring an additional 112,241 shares in the last quarter. Citigroup Inc. grew its holdings in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after acquiring an additional 1,941,993 shares in the last quarter. Geode Capital Management LLC increased its position in shares of agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after purchasing an additional 84,889 shares during the last quarter. Finally, Empowered Funds LLC acquired a new stake in shares of agilon health in the 4th quarter valued at about $97,000.

agilon health Stock Down 6.9 %

The firm has a market cap of $1.29 billion, a P/E ratio of -3.32 and a beta of 0.66. The firm’s 50-day moving average price is $2.96 and its 200 day moving average price is $3.03. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.